Feedback Share Discussion Threads

[hope67] 28/9/2019 20:04

right hand corner V shape click delete

[hope67] 28/9/2019 20:02

easy to delete a tweet if that is the problem.

[hope67] 28/9/2019 20:01

Stone Checker Software Ltd has an exclusive worldwide licence to apply the TexRAD® algorithm (provided by TexRAD Ltd., www.TexRAD.com, part of Feedback Plc) to examine heterogeneity and ‘texture’; not visible to the naked eye. Tested and validated at the University of Oxford, StoneChecker software has been available for research use since 2017 and is now available for commercial use outside the U.S.

[hazl] 28/9/2019 19:46

Perhaps it could be deleted?
Am still novice at Twitter I don't know,but might make GED feel happier.

[hope67] 28/9/2019 19:40

hazl it just shows Nomads are on twitter watching.

[hope67] 28/9/2019 19:39

Botak as for Ta I bought on the break out have been waiting a while to get back in third test would normally break out and then back test the support but they managed to squeeze it back down to the 20ma I am begining to wonder is someone is short here. Monday might surprise us so I really think you will regret it if you sell needs to clear 1.30 at the 50ma the blue line and there is a bit of resistance around 1.43 if it does clear that 1.58 is the next target at the 100ma purple line.

[hazl] 28/9/2019 19:33

I suspect he didn't like his post being quoted on Twitter.
Perhaps that was the one he had edited I don't know.....?

[hope67] 28/9/2019 19:28

The only positive thing I can say about the announcement is they can't release another speeding ticket now.

[hope67] 28/9/2019 19:27

Feedback PLC (LON:FDBK) shares surged on Friday after StoneChecker Software, a product of IQ-AI Limited (LON:IQAI) subsidiary Imaging Biometrics, received regulatory clearance by the US Food and Drug Administration (FDA).
READ: IQ-AI soars as StoneChecker software gets US FDA sign-off

StoneChecker, which is used to assess kidney stones, is a licensee of Feedback’s TexRAD software, however, the medical imaging firm it was currently not able to evaluate the level of income it would accrue as a result of the FDA clearance.

That didn’t stop the excitement from investors, as the shares jumped 16.3% to 1.3p in late-afternoon trading.

[hope67] 28/9/2019 19:25

GSA can't type your full name with out laughing as I bought in here literally 10 mins before the statement was released so hope you don't mind me abbreivating it.

Firstly thanks very much for contacting them I am sure every one here appreciates the feedback.

I am sorry but in all my time on Aim I have never seen a speeding ticket for a 10% rise. Also if this is the case why wasn't one given in July when the price rose from 0.76 to 0.216? Maybe its because it suited them to let the price rise to get a placing away. So that as you say is codswallop.

As far as I know the Nomad has to do thorough DD of a company before taking them on so I would assume they would of looked at the business model and read every rns before signing up. So surely they know Texrad has royalty rights attached. Why was this not mentioned in the statement?

I understand why they would want to prevent pi's thinking that Texrad had received automatic Fda approval just because Stonechecker got theres and that was a fair point to make but this where I am confused and I am hoping the lengths here can clear this up as I might have the wrong end of the stick but Iqai already have a commercial agreement for stonechecker in Europe [...] so do they not get royalties from that?

[digger2779] 28/9/2019 14:48

Thanks George. Nomads like to quote rules that should be stuck to when it suits. Ride roughshod through the other rules without batting an eyelid but just like teflon nothing sticks if they "get it wrong". Have seen loads of misleading RNS some of which were downright lies and when these are reported the FCA do FA (apart from lose a C).
I bought in here on the Bleepa hype a while back and am beginning to regret it if this is the calibre of management running the company. Seems like this bunch are doing their utmost to suppress the share price but why is that?

[ducatiman] 28/9/2019 13:47

George, good post and thank you for your time and effort. The phrase stitch up comes to mind. Silly nomad eh?
LR2, indeed, I feel quite sad and do hope all is well with Ged.

[botak54] 28/9/2019 13:41

Hope , I really appreciate TA, Thank You
In this case it is relevant coz volume of 22.84 M dictates we are in the realms of TA, The share price is in a precarious position monday AM, If volume is anywhere near Friday then the traders and Flipping Crew must be persuaded to hold through the 1.28 / 1.40 window to give the share price room to breathe and gap up , resistance point is where 1.28 must be ? , Next waypoint 1.50 , If we can break through that one surely 1.9 ? that,s why I,m hanging on like a Monkey to his Nuts !!

[lr2] 28/9/2019 13:37

Sad to see him go Duc. An intelligent and agreeable person.

[georgesorearse] 28/9/2019 13:37

Hi Hope,

I spoke to Nomad yday - he was very forthright that a statement had to come out as the share price had gone over 10% increase, we managed 16% at top then fell back, had altered faltered by time they got round to depressing it with the poorly worded RNS.

Nearly left their recent places back in profit from the 1.2 entry price.

I'm not sure he has ever looked at any other AIM share rises - 10% is nothing if you look at the risers and fallers boards daily - they don't get an RNS release at that level for many of them - so thats codswallop imo but the bloke was nice enough to talk to and defended his corner well - I just didn't agree with any of it.

The other point that had irritated them was that posters had put on the boards and social media that iqai approval meant that texrad also got approved so they felt the need to release an RNS against it - again codswallop imo - he told me to read the AIM rules that the guideline rises 10% and over requires an RNS - then he went on to explain percentages and not price increases ... it was a bit surreal at times ....

So we need to be aware that if we put stuff on social media they need to release an RNS immediately with no forethought or planning to correct that erroneous statement from some unknown and idiotic online Avatar ....

I think that because you can buy a play station with a game in the box and a controller on the American market and a mobile phone with pre - downloaded software and add ons that #BLEEPA could come in the box for every new Apple and Samsung phone that the Doctors can order along with Texrad or a version of Texrad in the bundle deal... if you go to Curries / P.C. World wearing a white clinicians jacket with a child's plastic stethoscope around your neck they will let you order one in the future .... i am trying to forward book mine under the name of Dr R.Runner who has requested a bleep bleep pa bundle ...

That statement summarises what I think of Fridays RNS and my conversation with the company Nomad, although as I say he stuck to his viewpoint that the RNS had to be released and unlike many Nomads did take a call from an unknown caller so he had his good points.

He further confirmed that the company and his firm had worked together to release that statement, I was shocked by that and confirmed that he hadn't steam rolled them into making that statement - he confirmed and repeated it, worked together as they do on every one.

IMO the Company need to get very organised with paperwork and thought processes - set out a clear method statement of what will be in their RNS releases and stick to it, their needs to be a quick learning process and some standing up to the Nomad to phrase released information in the correct light or replace the Nomad as he didn't come across as able to be flexible or easily amenable..

[ducatiman] 28/9/2019 13:21

Looks like it LR2. I do hope he is ok. Seemed a very intelligent and well balanced individual. Something has obviously happened since his last post.

[lr2] 28/9/2019 13:00

Has Ged left the building? All his terrific header information has disappeared.

[hope67] 28/9/2019 12:53

Botak I can see why you are so frustrated but please hang on.

[hope67] 28/9/2019 12:51

I take it someone asked the nomad to put the statement out as it was only 16% up maybe someone wanted cheap shares before the real update from what I gather the bod were taken by surprise by the rns. I get that they have been concentrating on Bleepa but jeez they certainly could of waited to gather all the facts and wait until Monday to release a proper update, the first thing they should of done was had a meeting with Aqai and discussed any possible future royalty payments.

[ducatiman] 28/9/2019 12:35

Agree Bo, totally unnecessary.

[botak54] 28/9/2019 12:05

Did anything about yesterdays RNS point to a Winning Team ?
Im on par with Linda Lovelace @ 50 , Just cant take anymore or I,l vomit ,

[ducatiman] 28/9/2019 10:48

I do hope we have not lost Bo and Ged. Respected and valued members.

[bobd29] 28/9/2019 00:26

Bo, hopefully you are not selling out. We need your balancing input to keep our feet on the ground should the share price ever rerate. Lths have certainly been frustrated by seemingly inaction and ineptitude over the years but I am hopeful that Prof Rory and TO may be a winning team. Keep with us mate, might get interesting?

[bobd29] 28/9/2019 00:21

My guess, and that’s all it is, is yes TexRAD will be sold eventually. Whether it is a distressed sale because our BOD could not commercialise a clinical version or whether they are successful and receive an offer from a larger group that could not be refused...that remains the question.
TO will be issuing a TexRAD update shortly and we may know more about clinical sale prospects after that. We will hopefully also hear how Bleepa is progressing as a commercial entity....revenue stream needed here ASAP.